2 Amino 6 propylaminotetrahydrobenzothiazole,
2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole,
2-amino-6-propylaminotetrahydrobenzothiazole,
4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine,
6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate,
dexpramipexole,
KNS 760704,
KNS-760704,
KNS760704,
Mirapex,
pramipexol,
pramipexol dihydrobromide, (+-)-isomer,
pramipexol dihydrochloride, (S)-isomer,
pramipexol, (+-)-isomer,
pramipexol, (R)-isomer,
pramipexole,
Pramipexole Dihydrochloride,
Pramipexole Dihydrochloride Anhydrous,
Pramipexole Hydrochloride Monohydrate,
Sifrol,
SND 919,
SND 919CL2x,
SND-919,
SND-919CL2x,
SND919CL2x,
104632-27-1,
DEXPRAMIPEXOLE DIHYDROCHLORIDE,
Dexpramipexole (dihydrochloride),
UNII-I9038PKO43,
CHEMBL3216394,
I9038PKO43,
(R)-Pramipexole Dihydrochloride,
SND 919CL2x,
KNS 760704,
C10H17N3S.2ClH,
SCHEMBL910147,
EX-A398,
2946AH,
BDBM50226714,
HY-17355A,
AKOS030485953,
API0005554,
CS-1195,
2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, dihydrochloride, (R)-,
Dexpramipexole dihydrochloride, >=98% (HPLC),
W-5567,
(R)-Pramipexole dihydrochloride;KNS 760704;SND 919CL2X,
Pramipexole Related Compound D, United States Pharmacopeia (USP) Reference Standard,
(R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride (Pramipexole Related Compound D), Pharmaceutical Secondary Standard; Certified Reference Material,
Pramipexole dihydrochloride,
A15066,
(R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino) benzothiazole dihydrochloride,
104632-25-9,